Does LEUPROLIDE Cause Nephrolithiasis? 134 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 134 reports of Nephrolithiasis have been filed in association with LEUPROLIDE (Fensolvi). This represents 0.2% of all adverse event reports for LEUPROLIDE.
134
Reports of Nephrolithiasis with LEUPROLIDE
0.2%
of all LEUPROLIDE reports
4
Deaths
74
Hospitalizations
How Dangerous Is Nephrolithiasis From LEUPROLIDE?
Of the 134 reports, 4 (3.0%) resulted in death, 74 (55.2%) required hospitalization, and 2 (1.5%) were considered life-threatening.
Is Nephrolithiasis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEUPROLIDE. However, 134 reports have been filed with the FAERS database.
What Other Side Effects Does LEUPROLIDE Cause?
Hot flush (9,146)
Death (8,772)
Intercepted product preparation error (8,621)
Syringe issue (7,847)
Device leakage (5,861)
Wrong technique in product usage process (5,062)
Fatigue (4,805)
Injection site pain (4,678)
Prostatic specific antigen increased (2,432)
Asthenia (2,176)
What Other Drugs Cause Nephrolithiasis?
ADALIMUMAB (2,416)
ETANERCEPT (1,292)
INFLIXIMAB (981)
METHOTREXATE (979)
ABATACEPT (788)
TOPIRAMATE (768)
CERTOLIZUMAB PEGOL (735)
RITUXIMAB (709)
TOFACITINIB (699)
SODIUM OXYBATE (698)
Which LEUPROLIDE Alternatives Have Lower Nephrolithiasis Risk?
LEUPROLIDE vs LEVALBUTEROL
LEUPROLIDE vs LEVAMISOLE
LEUPROLIDE vs LEVAQUIN
LEUPROLIDE vs LEVEMIR
LEUPROLIDE vs LEVETIRACETAM